Sumatriptan injection comes as a solution (liquid) to inject subcutaneously (just under your skin). It is usually used at the first sign of a migraine headache. If your symptoms improve after you use sumatriptan but return after 1 hour or longer, you may use a second dose of sumatriptan.
This report contains market size and forecasts of Injectable Sumatriptan in global, including the following market information:
Global Injectable Sumatriptan Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Injectable Sumatriptan Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Injectable Sumatriptan companies in 2021 (%)
The global Injectable Sumatriptan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
4mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Injectable Sumatriptan include GlaxoSmithKline, Pfizer, Teva and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Injectable Sumatriptan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Injectable Sumatriptan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Type, 2021 (%)
4mg
6mg
Others
Global Injectable Sumatriptan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Injectable Sumatriptan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Injectable Sumatriptan Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Injectable Sumatriptan revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Injectable Sumatriptan revenues share in global market, 2021 (%)
Key companies Injectable Sumatriptan sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Injectable Sumatriptan sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Pfizer
Teva
Sun Pharma